Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Urology in 2010].

P Jichlinski1

  • 1Service d'urologie, CHUV, 1011 Lausanne.

Revue Medicale Suisse
|February 12, 2011
PubMed
Summary
This summary is machine-generated.

In 2010, new urologic therapies improved management for benign prostatic hypertrophy, overactive bladder, and prostate and renal cancers. These advancements offered better treatment options for common urological conditions.

Related Concept Videos

Brain Abscess l: Introduction01:26

Brain Abscess l: Introduction

A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Abstracts from the 8th Annual Meeting of the Scientific Association of Swiss Radiation Oncology (SASRO).

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2016
Same author

[Urology. Trends in prostatic diseases in 2012].

Revue medicale suisse·2013
Same author

Intravaginal TLR agonists increase local vaccine-specific CD8 T cells and human papillomavirus-associated genital-tumor regression in mice.

Mucosal immunology·2012
Same author

[Urology in 2011].

Revue medicale suisse·2012
Same author

[Between quality, prostate, and surgery].

Revue medicale suisse·2012
Same author

[Quality assessment in urology].

Revue medicale suisse·2012
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

[Erythema multiforme : target deciphering].

Revue medicale suisse·2026
See all related articles

Area of Science:

  • Urology
  • Oncology
  • Pharmacology

Context:

  • In 2010, the field of urology saw significant therapeutic advancements.
  • These innovations aimed to enhance patient care for prevalent urological conditions.

Purpose:

  • To review the key therapeutic acquisitions in urology during 2010.
  • To highlight their impact on managing specific urological diseases.

Summary:

  • Therapeutic acquisitions in 2010 primarily focused on optimizing the management of benign prostatic hypertrophy (BPH).
  • Significant progress was made in treating overactive bladder (OAB).
  • The year also saw advancements in the treatment of localized and metastatic prostate cancer and renal cancers.

Impact:

Related Experiment Videos

  • Improved patient outcomes for BPH and OAB through optimized management strategies.
  • Enhanced treatment efficacy for both localized and advanced prostate and renal cancers.
  • Provided clinicians with updated therapeutic options for urological conditions in 2010.